-
CR Cement designed and provided high-performance marine cement for Hong Kong-Zhuhai-Macao BridgeOn the morning of the Oct 23, Chinese President Xi Jinping announced the official opening of the Hong Kong-Zhuhai-Macao Bridge during the opening ceremony in Zhuhai, Guangdong Province. The Hong Kong-Zhuhai-Macao Bridge is the first large-scale cross-sea traffic project jointly undertaken by Guangdong Province, Hong Kong Special Administrative Region and Macao Special Administrative Region, with a number of large state-owned enterprises playing a leading role in the constru...10/23/2018
-
CR Networks seals strategic cooperation agreement with BPOn October 18, 2018, a ceremony was held to mark the signing of a strategic cooperation agreement between China Resources Network (CR Networks) and British oil company BP at the China Resources Building in Hong Kong. Mr. Li Fuli, deputy general manager of China Resources Group, Andy Holmes, chief operating officer of BP Fuels ASPAC, and leading officials of CR Networks and BP China showed up at the ceremony.10/18/2018
-
JCI-CRHG Academy of Hospital Management Becomes Sole Consulting Service Supplier of JCI ChinaThe China Resources Healthcare Group Limited (CR Healthcare) has recently signed an agreement with the US-based Joint Commission International (JCI) on the Preparatory Services and Capital Increases for JCI Accreditation.07/12/2018
-
S&P Lifts Credit Rating of CR GasOn June 14, the internationally renowned rating agency S&P Global upgraded the credit rating of China Resources Gas from BBB+ to A- in a report, giving the company a stable outlook. This was a second upgrading for CR Gas by a major rating agency in this year. The first was given by Moody’s in March.07/12/2018
-
CR Gas Receives Highest Moody’s Rating in IndustryThe internationally renowned rating agency Moody’s has recently issued a report to upgrade China Resources Gas's credit rating from Baa1 to A3, the highest among the domestic industry, with a stable outlook. China Resources Gas (CR Gas) is the only company in domestic gas industry to receive this honor so far.03/05/2018
-
CR Power Given Best Award for Asian Sustainable Development ReportOn February 6, 2018, China Resources Power (CR Power) was given the Award for Best Environment Report in Asia, the Award for Most Transparent Report in Asia and the Award for Best Sustainable Development Report in Asia as CSRWorks, an Asia-based social responsibility authority, unveiled the 2017 Asian Sustainable Development Report Awards in Singapore. CR Power beat hundreds of competing companies to win these awards.02/08/2018
-
CR Pharma Signs Strategic Cooperation Agreement with American Company BDOn January 8, China Resources Pharmaceutical Group Limited (CR Pharma) signed an agreement with the Becton, Dickinson and Company (BD) on establishing strategic cooperation on “Innovative Commercial Channel Project”. The five-year partnership shall begin officially on February 1. Both parties are expected to leverage their strengths in quality production and broad sales coverage and bring their resource advantages with aligned concepts and professional abilities to carry ou...01/10/2018
-
CR Pharma Signs Strategic Cooperation Agreement with Swedish Xbrane BiopharmaOn December 7, China Resources Pharmaceutical Group Limited (CR Pharma) signed a strategic cooperation agreement with Swedish company Xbrane for the development of Xlucane, a biosimilar to Lucentis.12/11/2017
-
CR Power was Granted Three POWER-GEN International AwardsOn December 5-7, 2017, The 30th POWER-GEN International was held at the Las Vegas Convention Center. CR Power’s Xihuashan Project in Haiyuan County, Ningxia Hui Autonomous Region was named World Best Wind Power Project of the Year 2017 while the Hezhou Project and Cangzhou Project were respectively included among the World Best Coal-fired Power Plants of the Year 2017 and World Best Cogeneration Projects of the Year 2017, both taking second place.12/07/2017
-
CR Pharma Added in MSCI China IndexOn November 14, the China Resources Pharmaceutical (CR Pharma) was included in the MSCI (Morgan Stanley Capital International) China Index, effective on December 1, 2017. CR Pharma is also included in the Hang Seng China-Affiliated Corporations Index and the Hang Seng Mainland (Hong Kong Stock) Composite Index 100, effective from December 4, 2017.11/14/2017
Press Releases